| Therapeutic Translational Research Projects | University of California, Davis | Overcoming resistance to standard CD19-targeted CAR T using a novel triple antigen targeted vector |
$3,869,061 |
| Therapeutic Translational Research Projects | University of California, Davis | Placental Derived Natural Killer Cells to Target Solid Tumor Cancer Stem Cells (CSC) |
$0 |
| Transplantation Immunology | University of California, Davis | Donor natural killer (NK) cells as “veto” cells to promote donor-specific tolerance |
$1,257,601 |
